This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA
Book Now
Menu
Book

David De Lucrezia, PhD
Vice President and General Manager at TriLink Technologies
Speaker

Agenda Sessions

  • Advancing mRNA Therapeutics: AI-driven mRNA Design and Novel Modification Strategies for Improved Performance

    , 7:45am
    View Session

At this event

Prev
Next
Aimee Jackson, PhD
Founder
Jackson Bioscience Consulting

See David at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now